On May 8, 2018, the Board of Directors of Moog Inc. (the “Company”) adopted Amendment No. 2 (the “Amendment”) to the By-Laws of the Company (the “By-Laws”). The Amendment, which is effective immediately, deleted the provisions of ARTICLE III (EXECUTIVE COMMITTEE) of the By-Laws in its entirety and reserved such ARTICLE III for future use. As a result, the Executive Committee's governance, including its size, authority, and manner of conducting meetings, is subject to the same by-law provisions as the Board's other committees, which provisions are set forth in ARTICLE II, Section 2.11 of the By-Laws.

Amendment No. 2 to the By-Laws is set forth in Exhibit 3.1 hereto and is incorporated herein by reference.

(d)Exhibits.

MOOG INC. Exhibit
EX-3.1 2 exhibit31-050818.htm EXHIBIT 3.1 Exhibit Exhibit 3.1Amendment No. 2TO THE BY-LAWSof MOOG INC.The By-Laws of Moog Inc. are hereby amended,…
To view the full exhibit click here

About MOOG INC. (NYSE:MOG.A)

Moog Inc. is a designer, manufacturer and integrator of precision motion and fluid controls and systems for a range of applications in aerospace and defense and industrial markets. The Company has five segments: Aircraft Controls, Space and Defense Controls, Industrial Systems, Components and Medical Devices. Its Aircraft Controls segment designs, manufactures and integrates primary and secondary flight controls for military and commercial aircraft, and provides aftermarket support. Its Space and Defense Controls segment provides controls for satellites, space vehicles, launch vehicles, armored combat vehicles, tactical and strategic missiles, security and surveillance and other defense applications. Its Industrial Systems segment serves a global customer base across various markets. Its Components segment offers slip rings, fiber optic rotary joints, motors, sensors and handpieces product line. Its Medical Devices segment focuses on infusion therapy and enteral clinical nutrition.